Related Experiment Video
Updated: Jun 8, 2026

The bm12 Inducible Model of Systemic Lupus Erythematosus (SLE) in C57BL/6 Mice
Published on: November 1, 2015
Pediatric lupus in Asia
1Department of Pediatrics, Chang Gung Memorial Hospital, and Chang Gung University, Taoyuan, Taiwan. long@adm.cgmh.org.tw.
Insights
Pediatric-onset systemic lupus erythematosus (SLE) is common in Asia, with rashes, arthritis, and nephritis being key features. Infections significantly worsen outcomes for these children, though survival rates are improving.
Area of Science:
- Pediatric Rheumatology
- Autoimmune Diseases
- Epidemiology
Background:
- Systemic lupus erythematosus (SLE) onset before 16 years affects 15-20% of patients.
- Disease expression in SLE varies by environment and ethnicity.
- Understanding pediatric SLE in Asia is crucial due to regional differences.
Purpose of the Study:
- To review the prevalence of pediatric-onset SLE in Asia.
- To describe clinical manifestations and infectious complications.
- To assess outcomes and survival rates in Asian children with SLE.
Main Methods:
- Systematic review of literature on pediatric-onset SLE in Asia.
- Analysis of prevalence data, clinical features, and histopathology.
- Evaluation of infection rates, types, and their impact on outcomes.
Main Results:
- Prevalence in Asia: 6.3-19.3 per 100,000; female-to-male ratio 4.7-6.2.
- Common manifestations: cutaneous rashes, arthritis, hematological issues, nephritis (29-81%).
- Diffuse proliferative glomerulonephritis (Class IV) is the most common lupus nephritis type (39.4-54%); infections worsen outcomes.
Conclusions:
- Pediatric SLE in Asia presents with specific clinical and renal manifestations.
- Infections, particularly bacteremia from Gram-negative bacilli, are linked to poorer outcomes.
- Survival rates for pediatric SLE in Asia have improved, with 5-year survival at 92% in Taiwan (2008).
Abstract:
Of all patients with systemic lupus erythematosus (SLE), 15-20% are diagnosed during childhood, with disease onset prior to the age of 16 years. Because disease expression in SLE is influenced by environment factors and differs between racial and ethnic groups. The aims of this review were to describe prevalence, clinical manifestations, common infectious complications, and outcome of pediatric-onset SLE in Asia. The prevalence of pediatric-onset SLE was 6.3-19.3 per 100,000 in Asia. The ratio of female to male was 4.7-6.2. The mean age at diagnosis of pediatric-onset SLE was 8.6-13.5 years. The most common clinical features of pediatric-onset SLE in Asia were cutaneous rashes, arthritis, hematological involvement and nephritis. The occurrence of nephritis varies from 29% to 81%. The most common histopathology of lupus nephritis was diffuse proliferative glomerulonephritis (WHO Class-IV) which occurred in 39.4-54% of case of lupus nephritis. Pediatric-onset SLE patients with infections have poor outcomes than uninfected patients. Gram-negative bacilli are the most common microorganisms responsible for bacteremia in Asian patients with SLE. Recurrent major infections predict poorer disease outcome and associated organ damage in pediatric-onset SLE. Improving the survival of SLE patients was reported in Asia in recent decades. The survival was 92% at the age of 5 years, 86% at 10 years and 79% at 15 years in children with SLE in Taiwan in 2008.
Related Concept Videos
Pharmacokinetics in Pediatric Patients: Drug Metabolism
Pharmacokinetics in Pediatric Patients: Drug Excretion
Pharmacokinetics in Pediatric Patients: Drug Distribution
Pharmacokinetics in Pediatric Patients: Overview and Drug Absorption
iPS Cell Differentiation
Rocky Mountain Spotted Fever